SCHEMBL31727944

SCHEMBL31727944

[2H]C([2H])([2H])Oc1c(C#N)cc(-c2ccc(F)c(Cl)c2F)c2ncnc(N)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KHK P50053 1/20 0.38
▸ PIK3CD O00329 3/20 0.35
▸ PIK3CB P42338 3/20 0.35
▸ ABL1 P00519 2/20 0.35
▸ EGFR P00533 2/20 0.35
▸ HCK P08631 2/20 0.35
▸ SRC P12931 2/20 0.35
▸ KDR P35968 2/20 0.35
▸ PIK3CA P42336 2/20 0.35
▸ MTOR P42345 2/20 0.35
▸ PIK3CG P48736 2/20 0.35
▸ EPHB4 P54760 2/20 0.35
▸ PRKDC P78527 2/20 0.35
▸ MET P08581 1/20 0.33
▸ EIF2AK3 Q9NZJ5 3/20 0.33
▸ LRRK2 Q5S007 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ CLK1 P49759 2/20 0.32
▸ GRM4 Q14833 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31727929 0.93 KHK (0.37) KHKPIK3CDPIK3CBABL1EGFR
SCHEMBL31728139 0.90 KHK (0.34) KHKEGFRGRM4SIGMAR1EGLN2
SCHEMBL31728559 0.85 CLK1 (0.33) EPHB4METEIF2AK3CLK1
SCHEMBL31728772 0.81 KHK (0.39) KHKPIK3CDPIK3CBABL1EGFR
SCHEMBL31729173 0.81 CLK1 (0.35) PIK3CDPIK3CBABL1EGFRHCK
SCHEMBL31729227 0.81 IP6K1 (0.32) —
SCHEMBL31728352 0.80 PIK3CD (0.34) KHKPIK3CDPIK3CBABL1EGFR
SCHEMBL31728941 0.76 EIF2AK3 (0.39) PIK3CDPIK3CBABL1EGFRHCK
SCHEMBL31728591 0.76 EIF2AK3 (0.39) PIK3CDPIK3CBABL1EGFRHCK
SCHEMBL31728018 0.74 CLK1 (0.36) PIK3CDPIK3CBABL1EGFRHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback